As per the research report titled ‘Global Neurovascular Devices Market 2022-2028’, available with MarketStudyReport, global neurovascular devices market is expected to attain a valuation of USD 4590 million over 2022-2028, garnering a CAGR of 6.7% throughout.

The primary determinant for global neurovascular devices market expansion is a significant rise in the geriatric population. Also, increasing incidences of brain aneurysms, advancements in medical sector, poor lifestyle choices of people leading to chronic and neurovascular ailments, and higher preference for minimally invasive surgical procedures are also impelling the industry share.

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/5042752/

In addition to this, rising awareness campaigns around the world, enhanced utilization of neurovascular equipment, and a more severe regulatory framework by governments are also favouring the market growth.

Besides an extensive evaluation of the market situation, the research report also enlists the constraints and bottlenecks prevailing in the business sphere as well as the plausible alternatives that assist investors in generating better profits.

On top of that, the study consists of an in-depth evaluation of market size, key trends, competitive scenarios growth rate, and sub-segmentation. It also explores the influence of the COVID-19 outbreak on the overall industrial growth and economy.

Based on product type, worldwide neurovascular devices industry is bifurcated into thrombectomy devices (suction & aspiration devices, clot retrieval devices, snares), embolization devices (embolic coils, liquid embolic agent, flow diverter), angioplasty & stenting (embolic protection systems, carotid stenting), and access devices (guidewire, microcatheter).Among these, the embolization devices segment held a substantial share in 2021 and is estimated to attain a significant valuation by 2028.

Segmenting the market concerning end-users into specialized clinics, hospitals, and ambulatory surgical centers (ASCs). Based on the application spectrum, the market is classified into cerebral artery stenosis, cerebral aneurysm, ischemic strokes, arteriovenous malformation and fistulas (AVM), and others.

Moving on, major regional markets analyzed in the report are North America, Europe, and Asia Pacific among others. Details about the growth opportunities and existing trends in these geographies are entailed in the document.

The top-notch players in global neurovascular devices marketplace includes Terumo Medical Corporation, Rapid Medical Ltd., Oxford Endovascular Ltd., MicroPort Scientific Corporation, Johnson & Johnson, Stryker Corporation, Penumbra Inc., MIVI Neuroscience Inc., Medtronic plc, and EndoVasix Inc.